Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Monk

Showing results (341-350 of 738) with videos related to

Pageof 74
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 6, 2023
Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutionsThomas J Herzog, Shaun A Wahab, Mansoor R Mirza, et al.
Gynecologic Oncology|December 7, 2002
Laparoscopic photodynamic diagnosis of ovarian cancer using 5-aminolevulinic acid in a rat modelJohn K Chan, Bradley J Monk, David Cuccia, et al.
Gynecologic Oncology|November 19, 2013
Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paperThomas J Herzog, Deborah K Armstrong, Mark F Brady, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 11, 2025
Expanding the workforce of clinical trial investigators committed to gynecologic cancer research: the GOG Foundation, Inc's Scholar Career Development Award and New Investigator ProgramAngeles Alvarez Secord, Ronald D Alvarez, Leslie M Randall, et al.
Future Oncology (London, England)|September 6, 2022
EPIK-O/ENGOT-OV61: alpelisib plus olaparib vs cytotoxic chemotherapy in high-grade serous ovarian cancer (phase III study)Panagiotis A Konstantinopoulos, Antonio Gonzalez-Martin, Felipe Melo Cruz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2014
Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: a Gynecologic Oncology Group studyPaul A DiSilvestro, Shamshad Ali, Peter S Craighead, et al.
British Journal of Cancer|November 29, 2017
Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group StudyLeigh G Seamon, James J Java, Bradley J Monk, et al.
Gynecologic Oncology|July 6, 2015
Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpusJacques Bonneterre, Emilie Hutt, Jacques Bosq, et al.
The New England Journal of Medicine|February 21, 2014
Improved survival with bevacizumab in advanced cervical cancerKrishnansu S Tewari, Michael W Sill, Harry J Long, et al.
Gynecologic Oncology|March 16, 2021
The GOG partners: A program for industry sponsored clinical trials in gynecologic oncology within the GOG foundationBradley J Monk, Robert L Coleman, Thomas J Herzog, et al.
Pageof 74

Showing results (341-350 of 738) with videos related to

Sort By:
Pageof 74
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 6, 2023
Optimizing disease progression assessment using blinded central independent review and comparing it with investigator assessment in the PRIMA/ENGOT-ov26/GOG-3012 trial: challenges and solutionsThomas J Herzog, Shaun A Wahab, Mansoor R Mirza, et al.
Gynecologic Oncology|December 7, 2002
Laparoscopic photodynamic diagnosis of ovarian cancer using 5-aminolevulinic acid in a rat modelJohn K Chan, Bradley J Monk, David Cuccia, et al.
Gynecologic Oncology|November 19, 2013
Ovarian cancer clinical trial endpoints: Society of Gynecologic Oncology white paperThomas J Herzog, Deborah K Armstrong, Mark F Brady, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 11, 2025
Expanding the workforce of clinical trial investigators committed to gynecologic cancer research: the GOG Foundation, Inc's Scholar Career Development Award and New Investigator ProgramAngeles Alvarez Secord, Ronald D Alvarez, Leslie M Randall, et al.
Future Oncology (London, England)|September 6, 2022
EPIK-O/ENGOT-OV61: alpelisib plus olaparib vs cytotoxic chemotherapy in high-grade serous ovarian cancer (phase III study)Panagiotis A Konstantinopoulos, Antonio Gonzalez-Martin, Felipe Melo Cruz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2014
Phase III randomized trial of weekly cisplatin and irradiation versus cisplatin and tirapazamine and irradiation in stages IB2, IIA, IIB, IIIB, and IVA cervical carcinoma limited to the pelvis: a Gynecologic Oncology Group studyPaul A DiSilvestro, Shamshad Ali, Peter S Craighead, et al.
British Journal of Cancer|November 29, 2017
Impact of tumour histology on survival in advanced cervical carcinoma: an NRG Oncology/Gynaecologic Oncology Group StudyLeigh G Seamon, James J Java, Bradley J Monk, et al.
Gynecologic Oncology|July 6, 2015
Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpusJacques Bonneterre, Emilie Hutt, Jacques Bosq, et al.
The New England Journal of Medicine|February 21, 2014
Improved survival with bevacizumab in advanced cervical cancerKrishnansu S Tewari, Michael W Sill, Harry J Long, et al.
Gynecologic Oncology|March 16, 2021
The GOG partners: A program for industry sponsored clinical trials in gynecologic oncology within the GOG foundationBradley J Monk, Robert L Coleman, Thomas J Herzog, et al.
Pageof 74